Skip to main content
. 2017 Dec 27;14:83–93. doi: 10.2147/NDT.S149712

Table 1.

Baseline subject characteristics with hemispheric lesion verified by radiologic magnetic resonance imaging

Variables No IPSD n=338
Mean ± SD or n (%)
IPSD n=187
Mean ± SD or n (%)
t/χ2 P-value
Female 181 (53.6) 115 (61.5) 3.09 0.08
Age 65.4±10.9 67.4±11.4 -2.00 0.05
<9 years of education 130 (38.5) 67 (35.8) 0.36 0.57
Living alone 40 (11.8) 32 (16.0) 1.85 0.17
History of hypertension 224 (66.3) 130 (69.5) 0.58 0.45
History of diabetes 114 (33.7) 67 (35.8) 0.24 0.63
Lesion location
 Frontal lobe 14 (4.1) 14 (7.5) 2.67 0.10
 Parietal lobe 40 (11.8) 18 (9.6) 0.60 0.44
 Temporal lobe 18 (5.3) 11 (5.9) 0.07 0.79
 Occipital lobe 22 (6.5) 14 (7.5) 0.18 0.67
 Basal ganglia 103 (30.5) 68 (36.4) 1.90 0.17
 Thalamus 19 (5.6) 26 (13.9) 10.54 <0.01
 Brainstem 34 (10.1) 18 (9.6) 0.03 0.87
 Cerebellum 22 (6.5) 9 (4.8) 0.62 0.43
 Other location 18 (5.3) 10 (5.3) 0.00 0.99
 ≥ Two locations 31 (9.2) 11 (5.9) 1.78 0.18
 BI 71.48±16.11 68.90±17.34 1.71 0.09
 NIHSS score 4.91±2.54 5.35±2.55 -1.91 0.06
 BUN (mmol/L) 5.17±1.56 5.23±1.60 -0.43 0.67
 Cr (μmol/L) 67.15±17.96 65.97±18.91 0.70 0.48
 ALT (U/L) 21.77±9.28 20.42±9.13 1.61 0.11
 ALP (U/L) 71.30±17.36 70.10±18.94 0.74 0.46
 HAMD17 2.95±2.03 3.04±2.00 -0.45 0.66
Uric acid (μmol/L) 1.52 0.47
 ≤245.0 108 (32.0) 69 (36.9) 1.32 0.25
 245.0–330.0 117 (34.6) 57 (30.5) 0.93 0.34
 ≥330.0 113 (33.4) 61 (32.6) 0.04 0.85
Total bilirubin (μmol/L) 10.89 <0.01
 ≤8.0 119 (35.2) 62 (33.2) 0.22 0.64
 8.0–12.8 124 (36.7) 48 (25.7) 6.64 0.01
 ≥12.8 95 (28.1) 77 (41.2) 9.34 <0.01

Abbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase; BI, Barthel Index; BUN, blood urea nitrogen; Cr, creatinine; HAMD17, 17-item Hamilton Depression Rating Scale; IPSD, postischemic stroke depression; NIHSS, National Institute of Health Stroke Scale.